TY - JOUR
T1 - Changes of hepatic lipid mediators associated with intake of high-fat diet for 12 weeks in endotoxemic rats using LC-ESI-MS/MS
AU - Nishiokada, Aya
AU - Miyoshi, Makoto
AU - Fujiwara, Mayu
AU - Aoyama-Ishikawa, Michiko
AU - Maeshige, Noriaki
AU - Takahashi, Michiko
AU - Hamada, Yasuhiro
AU - Usami, Yu
AU - Honda, Mie
AU - Arita, Makoto
AU - Usami, Makoto
N1 - Funding Information:
This work was partially supported by JSPS KAKENHI (Grant-in-aid for Scientific Research), Grant Number 25450450 .
Publisher Copyright:
© 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Background & aims: It has recently been reported that anti-inflammatory lipid mediators are increased in the late phase of acute inflammation, whereas proinflammatory lipid mediators are regulated at the initiation of inflammation. The purpose of this study was to evaluate changes of hepatic lipid mediators due to high-fat diet (HFD) feeding in endotoxemic rats. Methods: Male Wistar rats were fed either HFD or control diet for 12 weeks, and were then killed 0, 1.5, and 6h after lipopolysaccharide (LPS) injection. Analyses included lipidomics assessment of mediators using liquid chromatography-electrospray ionization/multi-stage mass spectrometry; measuring expression of hepatic polyunsaturated fatty acid (PUFA)-oxidizing enzyme, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and inducible nitric oxide synthase mRNA levels; blood biochemical tests; and liver histology. Results: HFD feeding worsened liver injury, increased expression of TNF-α and IL-6 mRNA, and increased oxidative stress after LPS injection. PUFA-oxidizing enzymes were higher in HFD-fed rats after LPS injection. The proinflammatory prostaglandin (PG)E2 and thromboxane B2 were increased 1.5h after LPS injection, and had decreased by 6h in HFD-fed rats. In contrast, potent pro-resolving resolvins derived from eicosapentaenoic acid and docosahexaenoic acid were not detected, but anti-inflammatory epoxyeicosatrienoic acids, lipoxin A4, and 15-deoxy-PGJ2 were increased after LPS injection in HFD-fed rats. Conclusions: HFD feeding for 12 weeks enhanced proinflammatory lipid mediators 1.5h after LPS injection suggesting relation to liver injury.
AB - Background & aims: It has recently been reported that anti-inflammatory lipid mediators are increased in the late phase of acute inflammation, whereas proinflammatory lipid mediators are regulated at the initiation of inflammation. The purpose of this study was to evaluate changes of hepatic lipid mediators due to high-fat diet (HFD) feeding in endotoxemic rats. Methods: Male Wistar rats were fed either HFD or control diet for 12 weeks, and were then killed 0, 1.5, and 6h after lipopolysaccharide (LPS) injection. Analyses included lipidomics assessment of mediators using liquid chromatography-electrospray ionization/multi-stage mass spectrometry; measuring expression of hepatic polyunsaturated fatty acid (PUFA)-oxidizing enzyme, tumor necrosis factor (TNF)-α, interleukin (IL)-6, and inducible nitric oxide synthase mRNA levels; blood biochemical tests; and liver histology. Results: HFD feeding worsened liver injury, increased expression of TNF-α and IL-6 mRNA, and increased oxidative stress after LPS injection. PUFA-oxidizing enzymes were higher in HFD-fed rats after LPS injection. The proinflammatory prostaglandin (PG)E2 and thromboxane B2 were increased 1.5h after LPS injection, and had decreased by 6h in HFD-fed rats. In contrast, potent pro-resolving resolvins derived from eicosapentaenoic acid and docosahexaenoic acid were not detected, but anti-inflammatory epoxyeicosatrienoic acids, lipoxin A4, and 15-deoxy-PGJ2 were increased after LPS injection in HFD-fed rats. Conclusions: HFD feeding for 12 weeks enhanced proinflammatory lipid mediators 1.5h after LPS injection suggesting relation to liver injury.
KW - High-fat diet
KW - Lard
KW - Lipid mediator
KW - Lipidomics
KW - Lipopolysaccharide
KW - Sepsis
UR - http://www.scopus.com/inward/record.url?scp=84930762096&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930762096&partnerID=8YFLogxK
U2 - 10.1016/j.clnu.2014.07.013
DO - 10.1016/j.clnu.2014.07.013
M3 - Article
C2 - 25131602
AN - SCOPUS:84930762096
SN - 0261-5614
VL - 34
SP - 685
EP - 693
JO - Clinical Nutrition
JF - Clinical Nutrition
IS - 4
ER -